Eventide Asset Management - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 159 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q3 2021$38,397,000
-14.9%
578,0000.0%0.51%
-16.5%
Q2 2021$45,096,000
-5.6%
578,000
+14.5%
0.61%
-14.4%
Q1 2021$47,768,000
-32.8%
505,000
-13.4%
0.71%
-35.0%
Q4 2020$71,039,000
+112.3%
583,000
+52.2%
1.09%
+66.3%
Q3 2020$33,459,000
+35.3%
383,0000.0%0.66%
+21.7%
Q2 2020$24,738,000383,0000.54%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q2 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,737,297$176,802,0006.75%
MPM BioImpact LLC 308,686$19,938,0005.30%
Burrage Capital Management LLC 77,172$4,985,0003.49%
Orbimed Advisors 2,745,327$177,321,0002.50%
Parkman Healthcare Partners LLC 110,318$7,125,0002.01%
SECTORAL ASSET MANAGEMENT INC 284,486$18,375,0001.69%
First Light Asset Management, LLC 192,829$12,455,0001.45%
Asymmetry Capital Management, L.P. 22,608$1,460,0001.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,000$2,236,0000.74%
Prosight Management, LP 25,602$1,654,0000.71%
View complete list of TURNING POINT THERAPEUTICS I shareholders